Atlas Trials

Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh

Clinical trial NCT04402203 · UNKNOWN

Trial details

NCT number
NCT04402203
Sponsor
Bangladesh Medical Research Council (BMRC)
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19Favipiravir (Favipira)
Start date
2020-05-01
Primary completion
2020-07-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.